Skip to main content
FinSpry Logo
FinSpry
KROS logo
KROS
(NASDAQ)
Keros Therapeutics, Inc.
$10.92-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Keros Therapeutics (KROS) Stock Price & Financial Analysis

Keros Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$10.43 - $10.92
52-Week High$22.55
52-Week Low$9.69
Open$10.65
Volume400.52K
Average Volume (3M)302.82K
Market Cap403.20M
Shares Outstanding37.86M
Price to Sales (P/S)12.15
Price to Book (P/B)1.41
EV/EBITDA-1.35
Revenue (TTM)33.18M
Net Income (TTM)-85.14M
Free Cash Flow (TTM)-58.25M
EPS (TTM)$-2.17
Profit Margin-256.60%
Operating Margin-332.55%
Return on Equity (ROE)-29.81%
Debt to Equity0.06
50-Day MA$11.09
200-Day MA$14.97
52-Week Change-21.40%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About Keros Therapeutics

What is the current stock price for KROS?

As of the latest trading session, KROS stock trades at $10.65. The 52-week range is $9.69–$22.55, with a day range of $10.43–$10.92.

What is the P/E ratio for KROS?

The P/E ratio (Price-to-Earnings) for KROS is shown in the Key Statistics section. This valuation metric helps compare Keros Therapeutics, Inc. to industry peers.

Does KROS pay dividends?

Keros Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for KROS?

Based on 7 analysts, the consensus for KROS is Hold. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of KROS?

Keros Therapeutics's market capitalization is $403.2M, classifying it as a small-cap company. Keros Therapeutics operates in the Healthcare sector within the Biotechnology industry.